# The thrombelastometry parameter CTEXTEM as an independent risk factor for mortality in bleeding patients

**Authors:** Hagen Bomberg, Klaus Görlinger, Stefan Wagenpfeil, Thomas Volk, Sven Oliver Schneider

PMC · DOI: 10.1007/s00068-025-03079-z · 2026-02-16

## TL;DR

Prolonged clotting time (CTEXTEM) measured by rotational thromboelastometry is an independent predictor of 30-day mortality in bleeding patients.

## Contribution

CTEXTEM is shown to be an independent risk factor for mortality in bleeding patients across multiple clinical groups.

## Key findings

- CTEXTEM had predictive power for 30-day mortality in cardiothoracic surgery, trauma, and medical bleeding patients.
- Prolonged CTEXTEM remained an independent risk predictor for 30-day mortality after adjusting for confounding factors.
- Elevated CTEXTEM was associated with significantly higher 30-day mortality rates in all patient groups.

## Abstract

Pathologic thromboelastometric results may indicate a coagulation disorder. During bleeding, the prolongation of CTEXTEM (Clotting Time) measured by rotational thromboelastometry (ROTEM) can detect alterations in the extrinsic pathway. However, the significance of a prolonged CTEXTEM for risk stratification in patients with bleeding remains unclear.

A total of 2035 consecutive patients were retrospectively examined between 2014 and 2020 from a bleeding database at Saarland University Hospital. The database includes patients tested with ROTEM during bleeding. The study population was split into three groups: Cardiothoracic surgery with cardiopulmonary bypass (CPB, n = 753), trauma (n = 206) and medical bleeding (n = 1076). The impact of CTEXTEM on 30-day mortality was assessed using C-statistic. Threshold values for CTEXTEM reaching a specificity > 90% for 30-day mortality were selected. Adjusted hazard ratios (adjHR [95% confidence interval]) were calculated with multivariable Cox models.

The C-statistic showed that CTEXTEM (C-statistic for groups 1–3: 0.62, threshold ≥ 110 s (CPB); 0.65, threshold ≥ 98 s (trauma); 0.63, threshold ≥ 99 s (medical bleeding)) had a predictive power for 30-day mortality in all groups. The determined threshold value of CTEXTEM reaching a specificity > 90% remained an independent risk predictor for 30-day mortality even after adjustment for confounding factors (CPB: adjHR 2.5 [1.5–4.2], p < 0.001; trauma: adjHR 3.9 [1.8–8.7], p = 0.001; medical bleeding: adjHR 1.8 [1.4–2.5], p < 0.001). The 30-day mortality rate was significantly increased (CPB: CTEXTEM ≥ 110 s, 26% versus 9%, p < 0.001; trauma: CTEXTEM ≥ 98 s, 41% versus 11%, p < 0.001; medical bleeding: CTEXTEM ≥ 99 s, 41% versus 22%, p < 0.001).

Our results indicate that CTEXTEM-detected alterations in the extrinsic pathway may be an independent predictor of 30-day mortality in patients with bleeding.

The online version contains supplementary material available at 10.1007/s00068-025-03079-z.

Question: Bleeding can result in coagulation disorders. Rotational thromboelastometry can detect alterations in the extrinsic pathway by measuring clotting time (CTEXTEM). The significance of a prolonged CTEXTEM for risk stratification remains unclear.

Findings: 2035 consecutive patients between 2014 and 2020 were retrospectively analysed and threshold value of CTEXTEM remained an independent risk predictor for 30-day mortality.

Meaning: Elevated CTEXTEM could be an independent predictor of 30-day mortality in patients with bleeding.

The online version contains supplementary material available at 10.1007/s00068-025-03079-z.

## Full-text entities

- **Genes:** FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, F13A1 (coagulation factor XIII A chain) [NCBI Gene 2162] {aka F13A}, F7 (coagulation factor VII) [NCBI Gene 2155] {aka SPCA}, P2RY12 (purinergic receptor P2Y12) [NCBI Gene 64805] {aka ADPG-R, BDPLT8, HORK3, P2T(AC), P2Y(12)R, P2Y(AC)}, F10 (coagulation factor X) [NCBI Gene 2159] {aka FX, FXA}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** traumatic brain injury (MESH:D000070642), CPB (MESH:D006323), acute kidney and lung injury (MESH:D055371), mesenteric ischemia (MESH:D065666), polytrauma (MESH:D009104), factor deficiencies (MESH:D005171), impaired blood clotting (MESH:D020141), Pain (MESH:D010146), platelet dysfunction (MESH:D001791), Trauma (MESH:D014947), inflammatory (MESH:D007249), pulmonary embolism (MESH:D011655), Gastrointestinal ischemia (MESH:D007511), acute kidney injury (MESH:D058186), embolic apoplexy (MESH:D020521), pneumonia (MESH:D011014), von Willebrand disease (MESH:D014842), ROTEM (MESH:D009759), Bleeding (MESH:D006470), acidosis (MESH:D000138), haemorrhagic shock (MESH:D012771), vitamin K deficiency (MESH:D014813), thrombocytopenia (MESH:D013921), acute myocardial infarction (MESH:D009203), Coagulation disorders (MESH:D001778), brain injury (MESH:D001930), Deaths (MESH:D003643), deficiencies (MESH:D007153), Thrombosis and Hemostasis (MESH:D013927), hypothermia (MESH:D007035), disseminated intravascular coagulation (MESH:D004211), gastrointestinal bleeding (MESH:D006471), Prolongation (MESH:D008133), liver dysfunction (MESH:D017093), haemostatic dysfunction (MESH:D006331), thromboembolic (MESH:D013923), CTEXTEM (MESH:D000377), functional impairment of factor VII (MESH:D005168), peripheral arterial embolism (MESH:D058729)
- **Chemicals:** Phenprocoumon (MESH:D010644), Argatroban (MESH:C031942), tranexamic acid (MESH:D014148), Aspirin (MESH:D001241), Dabigatran (MESH:D000069604), CTEXTEM (-), heparin (MESH:D006493)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12909406/full.md

---
Source: https://tomesphere.com/paper/PMC12909406